Moderna asks FDA to approve its booster shot for all adults
Nov 18, 2021
The Moderna booster is half the dose of the initial vaccination series: 50 mcg versus 100 mcg.
Full approval of Pfizer COVID-19 vaccine could come in September
Aug 04, 2021
The FDA said in a statement that its leaders recognized that full approval might counter vaccine hesitancy.
FDA tells vaccine makers to update boosters to target omicron subvariants
Jun 30, 2022
Pfizer and Moderna are expected to start producing reformulated doses this summer.
FDA could approve Pfizer booster shots for all adults this week
Nov 17, 2021
More than 30 million Americans already have gotten booster shots.
FDA approves updated Novavax COVID-19 vaccine
Oct 04, 2023
The updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus.
FDA panel recommends approval of Johnson & Johnson booster shot
Oct 15, 2021
The booster shot is recommended for anyone 18 years and older, to be given at least two months after the first dose.
U.S. to recommend booster shots for most Americans
Aug 17, 2021
The first boosters will be given to nursing home residents, healthcare workers and emergency workers. U.S. health officials are concerned as data from Israel continue to suggest that the Pfizer vaccine’s...
More batches of Moderna COVID-19 shots shipped amid reports of shortages
Sep 22, 2022
While supplies of the updated Pfizer booster shot appear to be plentiful, some pharmacies have reported not having enough Moderna vaccine.
U.S. begins targeted vaccine rollout against monkeypox
Jun 29, 2022
HHS is rapidly expanding access to hundreds of thousands of doses of the Jynneos vaccine.
Decision on J&J COVID-19 vaccine booster doses could take weeks
Aug 20, 2021
Federal health officials are waiting on results from a government-backed clinical trial and from studies by Johnson & Johnson